secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRATED BIOPHARMA INC (INBP)
CIK:        0001016504
Form:       8-K
Filed at:   2021-11-29T23:59:59+00:00
Accession:  0001437749-21-027467
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

2021 annual meeting results: directors elected, executive compensation approved, auditor ratified
--------------------------------------------------------------------------------

- E Gerald Kay, Riva Sheppard, and Carl DeSantis elected as Class I directors until 2024 annual meeting.
- Non-binding advisory vote on executive compensation approved with 20.2M for, 0.7M against, 2.1M abstain.
- Ratification of Friedman LLP as independent auditor for FY ending June 30, 2022 approved (23.8M for, 6.4K against).
- Total shares voted: 24.1M out of 29.8M eligible (quorum present).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1016504/000143774921027467/0001437749-21-027467-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1016504/000143774921027467/inbp20211129_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-21-027467

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer